NurExone Biologic Inc. NRXBF
0.36 USD +0.02 (+5.12%)
At closeNov 9, 2026, 4:00 PM EST
0.3515 Day range 0.3515
0.3002 52-week range 0.535
- YTD
- -26.83%
- 1 year
- -28.02%
- Market cap
- 32.93M
- EPS (ttm)
- -0.08
- YTD return
- -26.83%
- 1-year return
- -28.02%
- Volume
- 10.00K
- Avg volume
- 9.85K
- Open
- 0.3515
- Previous close
- 0.34034
- Day's range
- 0.3515 – 0.3515
- 52-week range
- 0.3002 – 0.535
No chart data for this range yet.
News
NurExone Demonstrates Consistent Anti-Inflammatory Activity Across Three Separate Batches of Exosomes 
NurExone Demonstrates Scalable Exosome Production, Supporting Its Modular Manufacturing Strategy and Commercial Growth 
NurExone Expands U.S. Engagement Across Four Major Boston Life Sciences Events and Provides Corporate Update 
NurExone Announces Voting Results of Annual General and Special Meeting of Shareholders and Provides Corporate Update 
NurExone and NanoPass Technologies Ltd. to Collaborate on Integrated Exosome Delivery Approach for Regenerative Eye and Skin Applications 
NurExone Biologic Inc. Announces Second Quarter 2026 Financial Results 
NurExone Biologic Inc. to Present at the Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference 
NurExone Announces Annual General and Special Meeting to Consider Share Consolidation in Support of U.S. Capital Markets Strategy 
NurExone Announces Closing of C$1,066,078 Private Placement 
NurExone Reports New Preclinical Tissue-Analysis Data Supporting Potential Neuroprotective Effect of ExoPTEN in Acute Spinal Cord Injury Animal Model
Your note
Sign in to keep a note on NRXBF — it syncs with the Stock Master app.